Published May 11, 2026, 8:04 AM ET · Updated 6 months ago · 1 source

Heron Therapeutics misses top-line and bottom-line estimates; reaffirms FY26 outlook

Seeking Alpha
Seeking Alpha
·
Original Report

Heron Therapeutics misses top-line and bottom-line estimates; reaffirms FY26 outlook